Breaking

‘Mama, I’m tired – I want to die:’ Israel’s strikes in Gaza leave a generation of Palestinian children traumatized
French politician suggests US should give back Statue of Liberty for taking ‘the side of the tyrants’
Fear in Antarctic base as research team member is accused of assault
Putin just called Trump’s bluff on Ukraine, with the Russian art of the ‘no’ deal
Peru’s president ‘seriously considering’ extending death penalty amid crime surge
Hungary’s new anti-LGBTQ+ law bans Pride events and sparks protests
Peruvian fisherman rescued after 95 days at sea survived on diet of cockroaches, fish and turtle blood
US designates South Korea a ‘sensitive’ country over mishandling of lab data

World News
Science
Investing
Business
Search for:

Investing

Radiopharm achieves Nasdaq listing of ADS

November 27, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Radiopharm achieves Nasdaq listing of ADS

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Alvopetro Announces Year End 2024 Financial Results, Q1 2025 Dividend of US$0.10/share and Filing of our AIF

Independent Survey Confirms Public Support for Falco Horne 5 Project

Presentation to Food and Ingredients China 2025 Conference

Fill Out & Get More Relevant News

Your name

Your email

Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.
Categories
- Business (975)
- Investing (2,149)
- Science (573)
- World News (2,622)

Disclaimer: digitaltradecenter.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts
- Privacy Policy
- Terms & Conditions

Copyright © 2025 digitaltradecenter.com | All Rights Reserved

Top

World News
Science
Investing
Business

Type above and press Enter to search. Press Esc to cancel.